Yang, Chen Guang <br/><br/>
DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Jan 2011 
 - 49-56 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-010-1282-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Dihydropyrimidine Dehydrogenase Deficiency--genetics<br/>Dihydrouracil Dehydrogenase (NADP)--genetics<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fluorouracil--administration & dosage<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Pharmacogenetics<br/>Prospective Studies<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Treatment Outcome